Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens

Vaccine

Volumn 26, Issue 38, 2008, Pages 4904-4912

  Debba Pavard, Manel ^a   Ait Lounis, Aouatef ^a   Soubieux, Denis ^a   Rasschaert, Denis ^a,b   Dambrine, Ginette ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Marek's disease virus; Protection; Telomerase; Vaccine; Viral gene transcription

Indexed keywords

TELOMERASE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; ENZYME REGULATION; GENETIC TRANSCRIPTION; HERPESVIRUS OF TURKEY; LEUKOCYTE; MARDIVIRUS; MAREK DISEASE CVI988; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VACCINATION; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

ANIMALS; CHICKENS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HERPESVIRUS 2, GALLID; LEUKOCYTES; LYMPHOMA; MARDIVIRUS; MAREK DISEASE; MAREK DISEASE VACCINES; SPECIFIC PATHOGEN-FREE ORGANISMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 50049131067     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.038     Document Type: Article

References (52)

1. Osterrieder N., and Vautherot J.F. The genome content of Marek's disease-like viruses. In: Davison F., and Nair V. (Eds). Marek's disease: an evolving problem (2004), Elsevier, London 17-31
2. Nair V., and Kung H.J. Marek's disease virus oncogenicity: molecular mechanisms. In: Davison F., and Nair V. (Eds). Marek's disease: an evolving problem (2004), Elsevier, London 32-48
3. Calnek B.W. Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 255 (2001) 25-55
4. Baigent S., and Davison F. Marek's disease virus: biology and life cycle. In: Davison F., and Nair V. (Eds). Marek's disease: an evolving problem (2004), Elsevier, London 62-77
5. Burgess S.C., and Davison T.F. Identification of the neoplastically transformed cells in Marek' disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J Virol 76 14 (2002) 7276-7292
6. Abdul-Careem M.F., Hunter B.D., Sarson A.J., Parvizi P., Haghighi H.R., Read L., et al. Host responses are induced in feathers of chickens infected with Marek's disease virus. Virology 370 2 (2008) 323-332
7. Calnek B.W., Adldinger H.K., and Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis 14 2 (1970) 219-233
8. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis 41 1 (1997) 149-163
9. Rispens B.H., van Vloten H., Mastenbroek N., Maas H.J., and Schat K.A. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis 16 1 (1972) 108-125
10. Okazaki W., Purchase H.G., and Burmester B.R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis 14 2 (1970) 413-429
11. Bublot M., and Sharma J. Vaccination against Marek's disease. In: Davison F., and Nair V. (Eds). Marek's disease: an evolving problem (2004), Elsevier, London 168-185
12. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Rock D.L., and Kutish G.F. The genome of turkey herpesvirus. J Virol 75 2 (2001) 971-978
13. Spatz S.J., Petherbridge L., Zhao Y., and Nair V. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus. J Gen Virol 88 Pt 4 (2007) 1080-1096
14. Witter RL, Schat KA. Marek's disease. In: Saif YM, editor-in-chief. 11th ed. Diseases of Poultry. London, Iowa State Press, 2003:407-65.
15. Biggs P.M. The Leeuwenhoek Lecture. 1997, Marek's disease herpesvirus: oncogenesis and prevention. Philos Trans R Soc Lond B Biol Sci 352 1364 (1997) 1951-1962
16. Churchill A.E., and Biggs P.M. Agent of Marek's disease in tissue culture. Nature 215 5100 (1967) 528-530
17. Handberg K.J., Nielsen O.L., and Jørgensen P.H. The use of serotype 1- and serotype 3-specific polymerase chain reaction for the detection of Marek's disease virus in chickens. Avian Pathol 30 3 (2001) 243-249
18. Davidson I., Borenshtain R., and Weisman Y. Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens. J Vet Med B Infect Dis Vet Public Health 49 2 (2002) 83-87
19. Baigent S.J., Petherbridge L.J., Howes K., Smith L.P., Currie R.J., and Nair V.K. Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123 1 (2005) 53-64
20. Abdul-Careem M.F., Hunter B.D., Nagy E., Read L.R., Sanei B., Spencer J.L., et al. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek's disease virus genome load in feather tips. J Virol Methods 133 1 (2006) 34-40
21. Islam A.F., Walkden-Brown S.W., Islam A., Underwood G.J., and Groves P.J. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens. Avian Pathol 35 1 (2006) 42-48
22. Baigent S.J., Smith L.P., Currie R.J., and Nair V.K. Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation. J Gen Virol 86 Pt 11 (2005) 2989-2998
23. Baigent S.J., Smith L.P., Currie R.J., and Nair V.K. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathol 36 6 (2007) 467-474
24. Islam A., and Walkden-Brown S.W. Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. J Gen Virol 88 Pt 8 (2007) 2121-2128
25. Shkreli M., Dambrine G., Soubieux D., Kut E., and Rasschaert D. Involvement of the oncoprotein c-Myc in viral telomerase RNA (vTR) gene regulation during Marek's disease virus (MDV)-induced lymphomagenesis. J Virol 81 9 (2007) 4848-4857
26. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 33 5 (1997) 787-791
27. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., and Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276 5312 (1997) 561-567
28. Greider C.W., and Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 6205 (1989) 331-337
29. Fragnet L., Blasco M.A., Klapper W., and Rasschaert D. The RNA subunit of telomerase is encoded by Marek's disease virus. J Virol 77 10 (2003) 5985-5996
30. Quéré P., Rivas C., Ester K., Novak R., and Ragland W.L. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Arch Virol 150 3 (2005) 507-519
31. Abdul-Careem M.F., Hunter B.D., Parvizi P., Haghighi H.R., Thanthrige-Don N., and Sharif S. Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. Vaccine 25 3 (2007) 424-432
32. Uchida N., Otsuka T., Arima F., Shigematsu H., Fukuyama T., Maeda M., et al. Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leuk Res 23 3 (1999) 311-316
33. Holland M.S., Silva R.F., Mackenzie C.D., Bull R.W., and Witter R.L. Identification and localization of glycoprotein B expression in lymphoid tissues of chickens infected with turkey herpesvirus. Avian Dis 38 3 (1994) 446-453
34. Yang C.T., Song J., Bu X., Cong Y.S., Bacchetti S., Rennie P., et al. Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther 10 17 (2003) 1494-1502
35. Terrin L., Dolcetti R., Corradini I., Indraccolo S., Col J.D., Bertorelle R., et al. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis. Int J Cancer 121 3 (2007) 576-587
36. Maini M.K., Soares M.V., Zilch C.F., Akbar A.N., and Beverley P.C. Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J Immunol 162 8 (1999) 4521-4526
37. Yang F., Xian R.R., Li Y., Polony T.S., and Beemon K.L. Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas. Proc Natl Acad Sci USA 104 48 (2007) 18952-18957
38. Hrdlicková R., Nehyba J., Liss A.S., and Bose Jr. H.R. Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol 80 1 (2006) 281-295
39. Fragnet L., and Rasschaert D. Virus et Télomérase. Virologie 9 (2005) 443-455
40. Canela A., Martin-Caballero J., Flores J.M., and Blasco M.A. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 24 10 (2004) 4275-4293
41. Chang H., and Delany M.E. Complicated RNA splicing of chicken telomerase reverse transcriptase revealed by profiling cells both positive and negative for telomerase activity. Gene 379 (2006) 33-39
42. Delany M.E., and Daniels L.M. The chicken telomerase RNA gene: conservation of sequence, regulatory elements and synteny among viral, avian and mammalian genomes. Cytogenet Genome Res 102 1-4 (2003) 309-317
43. Fragnet L., Kut E., and Rasschaert D. Comparative functional study of the viral telomerase RNA based on natural mutations. J Biol Chem 280 25 (2005) 23502-23515
44. Trapp S., Parcells M.S., Kamil J.P., Schumacher F., Tischer B.K., Kumar P.M., et al. A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med 203 5 (2006) 1307-1317
45. Lee S.I., Ohashi K., Morimura T., Sugimoto C., and Onuma M. Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens. Arch Virol 144 1 (1999) 45-54
46. Buscaglia C., Nervi P., and Risso M. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Avian Pathol 33 2 (2004) 190-195
47. Butter C., Staines K., Baaten B., Smith L., and Davison T.F. Route of challenge is critical in determining the clinical outcome of infection with a very virulent oncogenic herpesvirus Marek's disease virus. Avian Pathol 36 2 (2007) 93-99
48. Reddy S.M., Witter R.L., and Gimeno I. Development of a quantitative-competitive polymerase chain reaction assay for serotype 1 Marek's disease virus. Avian Dis 44 4 (2000) 770-775
49. Yunis R., Jarosinski K.W., and Schat K.A. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 328 1 (2004) 142-150
50. Gimeno I.M., Witter R.L., Fadly A., and Silva R.F. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. Avian Pathol 34 4 (2005) 332-340
51. Jarosinski K.W., Yunis R., O'Connell P.H., Markowski-Grimsrud C.J., and Schat K.A. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis 46 3 (2002) 636-649
52. Gimeno I.M., Witter R.L., Hunt H.D., Reddy S.M., and Reed W.M. Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathol 33 1 (2004) 59-68